A PHASE 2, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

Project: Other project

StatusActive
Effective start/end date3/30/183/29/20

Funding

  • Pfizer, Inc.: $35,891.30